Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML
疾病发展过程中的对比要求确定 EZH2 是 AML 的治疗靶点
期刊:Journal of Experimental Medicine
影响因子:12.6
doi:10.1084/jem.20181276
Faisal Basheer, George Giotopoulos, Eshwar Meduri, Haiyang Yun, Milena Mazan, Daniel Sasca, Paolo Gallipoli, Ludovica Marando, Malgorzata Gozdecka, Ryan Asby, Olivia Sheppard, Monika Dudek, Lars Bullinger, Hartmut Döhner, Richard Dillon, Sylvie Freeman, Oliver Ottmann, Alan Burnett, Nigel Russell, E